Literature DB >> 6183083

Enolase isoenzymes in benign and malignant melanocytic lesions.

J A Royds, M A Parsons, I G Rennie, W R Timperley, C B Taylor.   

Abstract

The distributions of the alpha, beta and gamma subunits of enolase were studied in 34 melanocytic lesions using the peroxidase-antiperoxidase (PAP) technique. Melanocytes in benign neoplasms stained moderately strongly for both alpha enolase and gamma enolase but staining for beta enolase was consistently negative. Staining for alpha enolase was always stronger than that for gamma enolase. There are some indications that with increasing degrees of dedifferentiation there was a reduction of gamma enolase activity, least differentiated cells being completely negative. Ocular melanomata showed similar changes to those seen in the skin. The enolase isoenzyme composition of tumour extracts was assessed biochemically on a limited number of cases and these results are discussed in relationship to the immunohistochemical studies.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6183083

Source DB:  PubMed          Journal:  Diagn Histopathol        ISSN: 0272-7749


  4 in total

1.  Enolase isoenzymes in the cerebrospinal fluid of patients with diseases of the nervous system.

Authors:  J A Royds; G A Davies-Jones; N A Lewtas; W R Timperley; C B Taylor
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-11       Impact factor: 10.154

2.  The value of S-100 immunostaining as a diagnostic tool in human malignant melanomas. A comparative study using S-100 and neuron-specific enolase antibodies.

Authors:  D R Springall; J Gu; D Cocchia; F Michetti; A Levene; M M Levene; P J Marangos; S R Bloom; J M Polak
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1983

3.  Neuron-specific enolase and its mRNA are highly expressed in large congenital nevi: a study using immunocytochemistry, biochemical assay, and in situ hybridization.

Authors:  Q A Hamid; A E Bishop; D R Springall; C Adams; J M Polak; A A Quaba; A A al Nafussi; P J Marangos; E Ginns
Journal:  J Mol Neurosci       Date:  1989       Impact factor: 3.444

4.  Prognosis of conjunctival melanomas in relation to histopathological features.

Authors:  U Fuchs; T Kivelä; K Liesto; A Tarkkanen
Journal:  Br J Cancer       Date:  1989-02       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.